Eledon Pharmaceuticals (ELDN) EBITDA (2013 - 2026)
Eledon Pharmaceuticals (ELDN) EBITDA from Sep 30, 2013 to Mar 31, 2026. The TTM Eledon Pharmaceuticals (ELDN) EBITDA is -$74M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Eledon Pharmaceuticals (ELDN) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | -8.67% |
| 5 Years TTM | +22.97% |
| 10 Years TTM | +4.57% |
| All Time TTM | +12.69% |
Annual EBITDA change of Eledon Pharmaceuticals (ELDN)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$39M | -14.39% |
| 2025 | -$46M | +27.50% |
| 2024 | -$36M | -11.36% |
| 2023 | -$40M | -54.15% |
| 2022 | -$88M | +138.66% |
| 2021 | -$37M | +99.67% |
| 2020 | -$18M | +15.09% |
| 2019 | -$16M | +14.16% |
| 2018 | -$14M | +7.25% |
| 2017 | -$13M | +157.37% |
| 2016 | -$5.09M | -88.73% |
| 2015 | -$45M | +92.62% |
| 2014 | -$23M | +48.92% |
| 2013 | -$16M | +63.28% |
| 2012 | -$9.64M | N/A |
Comparison Eledon Pharmaceuticals (ELDN) five years EBITDA CAGR with competitors
Eledon Pharmaceuticals (ELDN) five years EBITDA CAGR is 41.59%.